Bivalirudin
Loading...
References
- Sunil V Rao. 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.. Journal of the American College of Cardiology, 2025
- J. D. Douketis. Perioperative Management of Patients Taking Direct Oral Anticoagulants: A Review.. JAMA, 2024
- B. Bikdeli. Bivalirudin Versus Heparin During PCI in NSTEMI: Individual Patient Data Meta-Analysis of Large Randomized Trials. Circulation, 2023
- Yi Li. Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial. The Lancet, 2022
- Jennifer S Lawton. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.. Journal of the American College of Cardiology, 2021
- D. Erlinge. Bivalirudin versus Heparin Monotherapy in Myocardial Infarction. The New England Journal of Medicine, 2017
- Emily Perdoncin. The comparative efficacy of bivalirudin is markedly attenuated by use of radial access: insights from Blue Cross Blue Shield of Michigan Cardiovascular Consortium.. European heart journal, 2016
- Yaling Han. Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.. JAMA, 2015